Mission of the Addiction Biobank
Our goal is to identify the genetic, molecular, cellular, and system mechanisms contributing to addiction to accelerate the development of novel biomarkers and the advance of personalized treatment for substance use disorders.
​
The Addiction Biobank includes brains, blood, urine, feces, liver, kidney, heart, spleen, ovary, testis, adrenals, colon, and other tissues using various storage methods to maximize compatibility with molecular and cellular approaches (genomic, transcriptomic, proteomic, metabolomic, neuroanatomy, etc...).
​
Animals are whole-genome sequenced and characterized by their propensity to develop addiction-like behaviors using intravenous or oral self-administration models of extended access to the drug.
​
We work collaboratively with researchers to select appropriate samples, analyze behavioral phenotypes of interest, and provide whole-genome sequencing.
​
If you are interested, contact us or fill out a request below to initiate a collaboration.
​
